International Journal of Hematology and Oncology
2024, Vol 34, Num 4 Page(s): 224-226
Back | Table of Contents | PDF | Mail to Author | |
Evaluation of Efficacy and Safety of Ponatinib as Third-line Treatment in Patients with the Diagnosis of Chronic Phase Chronic Myeloid Leukemia
Pusem PATIR1, Nur SOYER1, Filiz VURAL1, Guray SAYDAM1
Ege University Faculty of Medicine, Department of Hematology, Izmir, TURKEY
Pusem PATIR1, Nur SOYER1, Filiz VURAL1, Guray SAYDAM1
Ege University Faculty of Medicine, Department of Hematology, Izmir, TURKEY
Back | Table of Contents | PDF | Mail to Author | |